VERA - Why Shares of Vera Therapeutics Are Soaring Monday
2023-06-12 12:05:53 ET
Shares of Vera Therapeutics (NASDAQ: VERA) were up more than 18.8% Monday morning, after climbing as high as 25% shortly after the market opened. The healthcare stock 's move was likely triggered after one competitor with a similar lead therapy saw positive signs in a phase 1 trial, and another competitor agreed to a buyout offer from a larger pharmaceutical company.
Vera is presenting this week at the 44th Annual Goldman Sachs Global Healthcare Conference in Dana Point, California.
Vera Therapeutics is a clinical-stage biotech company that specializes in treating immunological diseases, particularly those involving the kidney. The company's lead therapy is atacicept, a fusion protein delivered by a weekly subcutaneous injection that helps block the production of autoantibodies that lead to autoimmune diseases. One of those diseases, BK virus, is often prevalent in kidney transplant patients.
For further details see:
Why Shares of Vera Therapeutics Are Soaring Monday